Discovery of 2,3‐Dihydro‐1 H ‐indene Derivatives as Novel GPR40 Agonists

GPR40 (G protein‐coupled receptor 40) has become an attractive target for insulin secretagogue via glucose‐dependent mechanism with low risk of hypoglycemia. In order to overcome problems associated with previously developed GPR40 agonists, we recruited the core fragment 2,3‐dihydro‐ 1 H ‐indene to...

Full description

Saved in:
Bibliographic Details
Published in:Bulletin of the Korean Chemical Society 2017-08, Vol.38 (8), p.861-868
Main Authors: An, Kyung‐Mi, Hong, Chang‐Hee, Kwak, Hyun‐Jung, Cui, Shuolin, Song, Hyo‐Jung, Park, Joon‐Tae, Moon, An‐Na, Kim, Jeong‐Ah, Yang, Ji‐Hun, Yoon, JongMin, Lee, MyongJae, Jeong, Dong‐Gu, Kim, Dohee, Lee, Don‐Gil, Shin, JeongCheol, Je, In‐Gyu, Lee, Hong‐Sub, Park, Soobong, Kang, Jae‐Hoon, Ko, Soo Young
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:GPR40 (G protein‐coupled receptor 40) has become an attractive target for insulin secretagogue via glucose‐dependent mechanism with low risk of hypoglycemia. In order to overcome problems associated with previously developed GPR40 agonists, we recruited the core fragment 2,3‐dihydro‐ 1 H ‐indene to GPR40 receptor binding pharmacophore with carboxylic acid moiety, and screened various amine analogs to finally discover several hit compounds displaying GPR40 agonistic activities. Through additional in vitro ADME , pharmacokinetics, and in vivo efficacy evaluations, compound 1e was demonstrated as a potent lead GPR40 agonist.
ISSN:1229-5949
1229-5949
DOI:10.1002/bkcs.11185